These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

42 related articles for article (PubMed ID: 3110346)

  • 1. Remission in non-insulin dependent diabetes.
    Ramachandran A; Snehalatha C; Mohan V; Viswanathan M
    J Med Assoc Thai; 1987 Mar; 70 Suppl 2():185-9. PubMed ID: 3110346
    [No Abstract]   [Full Text] [Related]  

  • 2. Metformin plus glyburide combination as initial therapy in type 2 diabetes: one month follow-up.
    Medina Santillán R; Reyes-García G; Mateos-García E
    Proc West Pharmacol Soc; 2002; 45():137-8. PubMed ID: 12434558
    [No Abstract]   [Full Text] [Related]  

  • 3. [Effect of glibenclamide therapy on the plasma insulin level in non-insulin-dependent diabetes].
    Liang JZ
    Zhonghua Yi Xue Za Zhi; 1984 Mar; 64(3):181-3. PubMed ID: 6432273
    [No Abstract]   [Full Text] [Related]  

  • 4. Insulin and IGF1 receptor function among type II diabetic responders and nonresponders to glyburide.
    Grunberger G
    J Lab Clin Med; 1993 Apr; 121(4):555-61. PubMed ID: 8454937
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Apolipoproteins in diabetes mellitus.
    Kostner GM; Schernthaner G
    Monogr Atheroscler; 1985; 13():12-24. PubMed ID: 3937046
    [No Abstract]   [Full Text] [Related]  

  • 6. Metformin plus glyburide combination as therapy in failure to monotherapy in type 2 diabetic patients: one month follow-up.
    Medina Santillán R; Reyes-García G; Mateos-García E
    Proc West Pharmacol Soc; 2002; 45():139-40. PubMed ID: 12434559
    [No Abstract]   [Full Text] [Related]  

  • 7. Serum C-peptide after 6 months on glibenclamide remains higher than during insulin treatment.
    Peacock I; Watts R; Selby C; Tattersall RB
    Diabetes Res; 1987 Oct; 6(2):57-9. PubMed ID: 3123115
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Combined glyburide and insulin therapy in type II diabetes.
    Reich A; Abraira C; Lawrence AM
    Diabetes Res; 1987 Oct; 6(2):99-104. PubMed ID: 3123116
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Diabetes control in the elderly: a randomized, comparative study of glyburide versus glipizide in non-insulin-dependent diabetes mellitus.
    Rosenstock J; Corrao PJ; Goldberg RB; Kilo C
    Clin Ther; 1993; 15(6):1031-40. PubMed ID: 8111800
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [25 years of diabetic treatment by oral hypoglycemic agents: successes and failures].
    Tattersall RB
    Journ Annu Diabetol Hotel Dieu; 1984; ():183-91. PubMed ID: 6443219
    [No Abstract]   [Full Text] [Related]  

  • 11. The honeymoon period in non-insulin-dependent diabetes mellitus.
    Crump WJ
    J Fam Pract; 1987 Jul; 25(1):78-9, 82. PubMed ID: 3598482
    [No Abstract]   [Full Text] [Related]  

  • 12. Comparison of acute and prolonged effects of glibenclamide and chlorpropamide in patients with non-insulin-dependent diabetes.
    Ylitalo P; Oksala H; Pitkäjärvi T
    Arzneimittelforschung; 1985; 35(10):1596-9. PubMed ID: 3935120
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Insulin-dependent diabetes of pregnancy treated with the combination of sulfonylurea and insulin.
    Ravina A
    Isr J Med Sci; 1995 Oct; 31(10):623-5. PubMed ID: 7591687
    [No Abstract]   [Full Text] [Related]  

  • 14. [Micronized glibenclamide. Preliminary findings concerning pharmacokinetics and pharmacotherapy].
    Dani F; Massarenti P; Carta Q; Caselle MT; Dal Molin V; Vitelli A
    Minerva Endocrinol; 1984; 9(2):303-8. PubMed ID: 6438467
    [No Abstract]   [Full Text] [Related]  

  • 15. Changes in platelet aggregation caused by glyburide in diabetic patients.
    De Bellis R; Novoa E; Dol B; Cazerez J; Arroyo G; Balbela B; Navarro A
    Clin Ther; 1984; 6(3):335-43. PubMed ID: 6426797
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Weight loss reverses secondary failure of oral hypoglycaemic agents in obese non-insulin-dependent diabetic patients independently of the duration of the disease.
    Pontiroli AE; Calderara A; Pacchioni M; Cassisa C; Pozza G
    Diabete Metab; 1993; 19(1):30-5. PubMed ID: 8504882
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Insulin, glibenclamide plus acarbose in diabetes mellitus?].
    Hauner H
    Dtsch Med Wochenschr; 1995 Nov; 120(46):1605. PubMed ID: 7588044
    [No Abstract]   [Full Text] [Related]  

  • 18. [Proliferative activity of the gastric epithelium: changes due to therapy in patients with association of gastric ulcer and diabetes mellitus].
    Fedorchenko IuL; Goncharova EN; Koblova NM
    Khirurgiia (Mosk); 2001; (6):43-6. PubMed ID: 11517701
    [No Abstract]   [Full Text] [Related]  

  • 19. [Pharmacokinetic and clinical study on glibenclamide].
    Chen H
    Zhonghua Yi Xue Za Zhi; 1987 Oct; 67(10):533-5, 32. PubMed ID: 3127003
    [No Abstract]   [Full Text] [Related]  

  • 20. Prolonged response to glibenclamide in NIDDM patients in a normoglycemic state.
    Raz I; Gilhar D; Hoffman A
    Isr J Med Sci; 1994 Oct; 30(10):775-8. PubMed ID: 7960692
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 3.